Evaluation of efficacy of Vratisolin 2% in the treatment of epidemic conjunctivitis

38 patients (18 males, 20 females), age from 17 to 61 years, were assigned in two groups. Group 1 including 29 patients (53 eyes), vratisolin 2% ophthalmic ointment was applied 4-5 times daily into the conjunctive sac. Group 2 including 9 patients (15 eyes), Ofus ophthalmic eyes drops was used 10 times daily. Results: in patients with epidemic conjunctivitis, treated by Vratisolin, more rapid reduction of symptoms was observed in comparing with this the group treated with Ofus eye drops.